Management of recurrent melanoma of the extremity
Publication
, Journal Article
Shingleton, WW; Seigler, HF
Published in: EXCERPTA MEDICA, ICS NO. 354
1975
Perfusion chemotherapy with Phenylalanine mustard was employed for treatment of patients with recurrent melanoma limited to the extremity, and has resulted in a 5 yr survival rate of 28% in 43 patients. The side effects of this form of treatment have been minimal, and major extremity amputation has been avoided. The survival rates are approximately those which have been previously reported with major extremity amputation.
Duke Scholars
Published In
EXCERPTA MEDICA, ICS NO. 354
Publication Date
1975
Volume
vol.6
Start / End Page
103 / 106
Citation
APA
Chicago
ICMJE
MLA
NLM
Shingleton, W. W., & Seigler, H. F. (1975). Management of recurrent melanoma of the extremity. EXCERPTA MEDICA, ICS NO. 354, vol.6, 103–106.
Shingleton, W. W., and H. F. Seigler. “Management of recurrent melanoma of the extremity.” EXCERPTA MEDICA, ICS NO. 354 vol.6 (1975): 103–6.
Shingleton WW, Seigler HF. Management of recurrent melanoma of the extremity. EXCERPTA MEDICA, ICS NO 354. 1975;vol.6:103–6.
Shingleton, W. W., and H. F. Seigler. “Management of recurrent melanoma of the extremity.” EXCERPTA MEDICA, ICS NO. 354, vol. vol.6, 1975, pp. 103–06.
Shingleton WW, Seigler HF. Management of recurrent melanoma of the extremity. EXCERPTA MEDICA, ICS NO 354. 1975;vol.6:103–106.
Published In
EXCERPTA MEDICA, ICS NO. 354
Publication Date
1975
Volume
vol.6
Start / End Page
103 / 106